Cn1ccnc1Sc1ccc(/C=N/c2ccc3nc(SCC(=O)NC4CCCCC4)sc3c2)cc1[N+](=O)[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?